Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 21, 2026; 32(43): 121310
Published online Nov 21, 2026. doi: 10.3748/wjg.121310
Published online Nov 21, 2026. doi: 10.3748/wjg.121310
Table 1 Stage-specific operational framework for neutrophil-hepatic stellate cells crosstalk and therapeutic posture
| Stage | Clinical/histological window | Dominant cellular-molecular signature | Neutrophil functional output | Therapeutic posture |
| I Acute injury (hours-days) | ALT/AST ↑↑, no fibrosis | Ly6Ghi infiltration peak; transient MPO-DNA/cit-H3↑; early αSMA induction | Dual: Early cytotoxic; late reparative | Selective: PAD4 inhibition + NLRP3 dampening in early window; preserve late reparative phenotype |
| II Chronic active fibrosis (months-years) | NLR ↑, FibroScan ≥ 8.5 kPa or ELF ≥ 9.8, F2-F3 | Sustained MPO-DNA/cit-H3 ↑; CCL2, CXCL10 ↑; persistent NETs-HSCs loop | Self-amplifying pro-fibrotic | Disrupt loop: COX-2 + NLRP3 + TGFβR1; avoid prolonged NETs ablation |
| III Cirrhosis/HCC (F4+ tumor) | High NLR, PIVKA-II/AFP ↑ | PD-L1+/PLAUR+ TANs; NETs-rich immune-excluded niche | Pro-tumor, immunosuppressive | Combination: PAD4 or NLRP3 + TGFβR1 + ICI; close infection monitoring |
- Citation: Lian YJ, Li MY, Wang L, Gao YW, Zhu D, Lyu WL. Crosstalk between neutrophils and hepatic stellate cells in liver injury and repair: Mechanisms and implications. World J Gastroenterol 2026; 32(43): 121310
- URL: https://www.wjgnet.com/1007-9327/full/v32/i43/121310.htm
- DOI: https://dx.doi.org/10.3748/wjg.121310